These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 17150778)

  • 1. A novel method to generate aptamers against recombinant targets displayed on the cell surface.
    Ohuchi SP; Ohtsu T; Nakamura Y
    Nucleic Acids Symp Ser (Oxf); 2005; (49):351-2. PubMed ID: 17150778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of RNA aptamers against recombinant transforming growth factor-beta type III receptor displayed on cell surface.
    Ohuchi SP; Ohtsu T; Nakamura Y
    Biochimie; 2006 Jul; 88(7):897-904. PubMed ID: 16540230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complex target SELEX.
    Shamah SM; Healy JM; Cload ST
    Acc Chem Res; 2008 Jan; 41(1):130-8. PubMed ID: 18193823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Selection and identification of DNA aptamers against DC-SIGN].
    Chen F; Zeng J; Sun P; Pan Q; Zhang XL
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Dec; 24(12):1133-6. PubMed ID: 19068192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of DNA aptamers against VEGF165 using a protein competitor and the aptamer blotting method.
    Hasegawa H; Sode K; Ikebukuro K
    Biotechnol Lett; 2008 May; 30(5):829-34. PubMed ID: 18175068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of DNA aptamers against multiple proteins in tissue.
    Noma T; Ikebukuro K; Sode K; Ohkubo T; Sakasegawa Y; Hachiya N; Kaneko K
    Nucleic Acids Symp Ser (Oxf); 2005; (49):357-8. PubMed ID: 17150781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro selection using a dual RNA library that allows primerless selection.
    Jarosch F; Buchner K; Klussmann S
    Nucleic Acids Res; 2006 Jul; 34(12):e86. PubMed ID: 16855281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease-specific biomarker discovery by aptamers.
    Ulrich H; Wrenger C
    Cytometry A; 2009 Sep; 75(9):727-33. PubMed ID: 19565638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection and characterization of DNA aptamers against VEGF165 with aptamer blotting method and its application.
    Ikebukuro K; Hasegawa H; Sode K
    Nucleic Acids Symp Ser (Oxf); 2007; (51):399-400. PubMed ID: 18029755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subtractive SELEX against two heterogeneous target samples: numerical simulations and analysis.
    Chen CK; Kuo TL; Chan PC; Lin LY
    Comput Biol Med; 2007 Jun; 37(6):750-9. PubMed ID: 16920093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development and testing of aptamers for cancer.
    Barbas AS; White RR
    Curr Opin Investig Drugs; 2009 Jun; 10(6):572-8. PubMed ID: 19513946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of Aptamers Against Whole Living Cells: From Cell-SELEX to Identification of Biomarkers.
    Quang NN; Miodek A; Cibiel A; Ducongé F
    Methods Mol Biol; 2017; 1575():253-272. PubMed ID: 28255886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective isolation of RNA aptamer through suppression of PCR bias.
    Tsuji S; Hirabayashi N; Kato S; Akitomi J; Egashira H; Tanaka T; Waga I; Ohtsu T
    Biochem Biophys Res Commun; 2009 Aug; 386(1):223-6. PubMed ID: 19520057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of different strategies to select aptamers against a transmembrane protein target.
    Pestourie C; Cerchia L; Gombert K; Aissouni Y; Boulay J; De Franciscis V; Libri D; Tavitian B; Ducongé F
    Oligonucleotides; 2006; 16(4):323-35. PubMed ID: 17155908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands.
    Stoltenburg R; Reinemann C; Strehlitz B
    Biomol Eng; 2007 Oct; 24(4):381-403. PubMed ID: 17627883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human growth hormone-specific aptamer identification using improved oligonucleotide ligand evolution method.
    Calik P; Balci O; Ozdamar TH
    Protein Expr Purif; 2010 Jan; 69(1):21-8. PubMed ID: 19500672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of aptamers for molecular recognition and characterization of cancer cells.
    Tang Z; Shangguan D; Wang K; Shi H; Sefah K; Mallikratchy P; Chen HW; Li Y; Tan W
    Anal Chem; 2007 Jul; 79(13):4900-7. PubMed ID: 17530817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in SELEX and application of aptamers in the central nervous system.
    Yang Y; Yang D; Schluesener HJ; Zhang Z
    Biomol Eng; 2007 Dec; 24(6):583-92. PubMed ID: 17681489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-specific internalization study of an aptamer from whole cell selection.
    Xiao Z; Shangguan D; Cao Z; Fang X; Tan W
    Chemistry; 2008; 14(6):1769-75. PubMed ID: 18092308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-SELEX-based selection of aptamers that recognize distinct targets on metastatic colorectal cancer cells.
    Li WM; Bing T; Wei JY; Chen ZZ; Shangguan DH; Fang J
    Biomaterials; 2014 Aug; 35(25):6998-7007. PubMed ID: 24857291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.